Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
ACE Report #10103
Ace Report Cover Arthroplasty

No significant difference in DVT incidence between aspirin vs rivaroxaban in total knee arthroplasty

Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A

Venous thromboembolism prophylaxis after total knee arthroplasty (TKA): aspirin vs. rivaroxaban

Rev Bras Ortop. 2017 Dec 6;53(1):22-27

Contributing Authors: JL Colleoni FN Ribeiro PAC Mos JP Reis HR Oliveira BK Miura

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here


32 patients scheduled for total knee arthroplasty were randomized to thromboprophylaxis with either rivaroxaban 10mg daily or aspirin 300mg daily for 14 days after surgery. Patients were assessed for deep vein thrombosis rate, local complication rate, systemic complication rate, reoperation rate, mortality rate, postoperative blood loss, and hemoglobin and hematocrit drop. Of primary consideration...

To view the full report, start your 30-day free trial today

No credit card required

JOIN Forgot Password?

Not sure if you want to join OrthoEvidence?

Access this report without an Account.

Success, an email containing a link to access this report has been sent to your inbox.

CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.


Please Login or Join to leave comments.